Trial Profile
A study retrospective, prospective, multicenter, study investigating the effect of fingolimod in multiple sclerosis patients from Spanish registry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms GILENYA registry
- 12 Dec 2015 New trial record